Immuno AG
Immuno AG was a major[1] Pharmaceutical company founded in 1960 by Dr. Otto Schwarz & Dr. Hans Eibl[2] with headquarters in Vienna, Austria.[3]
In 1996 the company was acquired by Baxter for $715 Million.[4]
Business[]
Immuno manufactured blood products including Factor VIII and Factor IX[5] such as Kryobulin and Krobulin TIM.[6]
Lawsuits[]
In 1983 Immuno sued Dr. Shirley McGreal and several others claiming $4 million in damages for an article claiming the company planned to use captured chimpanzees for hepatitis research in Sierra Leone.[7][8]
In 1986 two civil lawsuits were brought against Immuno by the Association Against Animal Experimentation in regards to treatment of Chimpanzees.[9]
References[]
- ^ Whiteside, R. M.; Wilson, A.; Blackburn, S.; Hörnig, S. E.; Wilson, C. P. (6 December 2012). Major Companies of Europe 1990/91 Volume 3: Major Companies of Western Europe Outside the European Economic Community. Springer Science & Business Media. ISBN 9789400908017 – via Google Books.
- ^ Stern, Joe. "In Memoriam of Dr. Otto Schwarz - Plasma Protein Therapeutics Association (PPTA)".
- ^ "Immuno AG".
- ^ Thomas M. Burton (30 August 1996). "Baxter Confirms Pact To Acquire Immuno". Wall Street Journal.
- ^ "Method of producing a factor-VIII(AHF)-high-concentrate".
- ^ "Final Report: Chapter 23 - Viral Inactivation of Blood Products for Haemophilia Therapy up to 1985".
- ^ "Abroad at Home; Abusing The Law". The New York Times. 10 May 1991.
- ^ "IMMUNO, A.G., APPELLANT, v. JAN MOOR-JANKOWSKI, RESPONDENT".
- ^ Information, Reed Business (21 August 1986). "New Scientist". Reed Business Information – via Google Books.
Categories:
- Pharmaceutical companies established in 1960
- Manufacturing companies based in Vienna
- Pharmaceutical companies of Austria
- Baxter International
- Austrian companies established in 1960
- Pharmaceutical companies disestablished in 1996
- 1996 disestablishments in Austria
- 1996 mergers and acquisitions